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Introduction
Climate change is likely to affect allergic 
disease (Smith et al. 2014), and the view of 
clinical experts is that these diseases will 
increase under climate change (Bielory et al. 
2012) in part because of the impact on aller-
genic plant species (Shea et al. 2008). Impacts 
on allergens may be one of the most important 
consequences of climate change for human 
health (Beggs 2015). Climate change has 
already been suggested as one factor behind the 
increasing prevalence of allergic asthma (Beggs 
and Bambrick 2005). Pollens are a major 
cause of symptoms in people with allergic 
disease, but there is no quantitative assessment 
of how future climate change may affect the 
levels of pollen allergy in humans because 
the influence of climate change is complex 
(Reid and Gamble 2009; Smith et al. 2014). 
For example, an altered climate will affect the 
range of allergenic species as well as the timing 
and length of the pollen season, and elevated 
carbon dioxide (CO2) may increase plant 
productivity and pollen production (Beggs 
2015). Climate change may also affect the 
release and atmospheric dispersion of pollen 
(Bielory et al. 2012). The overall impact will 
be alteration of pollen season timing and load, 
and hence, changes in exposure. Modeling all 
of these processes is needed to assess the conse-
quences of climate change on pollen-related 
allergic disease. Previous studies (reviewed by 
Bielory et al. 2012) have only examined some 
of the processes along this pathway.
Allergic disease is a key public health 
problem that has increased rapidly in recent 
decades in both developed and developing 
countries, and it is now recognized as 
a major global epidemic (Pawankar 2014; 
Platts-Mills 2015). The economic burden of 
allergic disease is considerable. In 2007, the 
total cost of allergic disease to the United 
States was 19.7 billion USD, and estimates 
for the European Union range from 55 to 
151 billion EUR (Zuberbier et al. 2014). In 
terms of specific allergic diseases, the World 
Health Organization (WHO) estimates that 
400 million people in the world suffer from 
allergic rhinitis and 300 million from asthma 
(Bousquet and Khaltaev 2007). Within 
Europe, the prevalence of pollen allergy in 
the general population is estimated at 40% 
(D’Amato et al. 2007).
Here, we quantify the potential conse-
quences of climate change on pollen allergy, 
focusing upon the annual herbaceous plant 
common ragweed (Ambrosia artemisiifolia) in 
Europe (henceforth referred to as ragweed). 
In Europe, ragweed is an introduced species 
in the middle of an ongoing invasion event 
(Storkey et al. 2014) and, therefore, represents 
a case of a human population being progres-
sively exposed to a novel allergen. Ragweed is 
highly invasive; it thrives on disturbed land, 
with each plant producing ≤ 62,000 seeds 
per year. Ragweed is particularly harmful for 
public health because each plant produces a 
large amount of pollen (≤ 1 billion grains a 
year; Fumanal et al. 2007), and its allergenic 
potential is high (Taramarcaz et al. 2005). 
Unlike other types of pollen, ragweed pollen 
peaks in the late summer (Essl et al. 2015). 
In some parts of Europe, ragweed generates 
~50% of the total pollen production. In the 
United States, where ragweed is native, > 26% 
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Background: Globally, pollen allergy is a major public health problem, but a fundamental 
unknown is the likely impact of climate change. To our knowledge, this is the first study to quantify 
the consequences of climate change upon pollen allergy in humans.
oBjectives: We produced quantitative estimates of the potential impact of climate change upon 
pollen allergy in humans, focusing upon common ragweed (Ambrosia artemisiifolia) in Europe.
Methods: A process-based model estimated the change in ragweed’s range under climate change. 
A second model simulated current and future ragweed pollen levels. These findings were translated 
into health burdens using a dose–response curve generated from a systematic review and from 
current and future population data. Models considered two different suites of regional climate/
pollen models, two greenhouse gas emissions scenarios [Representative Concentration Pathways 
(RCPs) 4.5 and 8.5], and three different plant invasion scenarios.
results: Our primary estimates indicated that sensitization to ragweed will more than double in 
Europe, from 33 to 77 million people, by 2041–2060. According to our projections, sensitization 
will increase in countries with an existing ragweed problem (e.g., Hungary, the Balkans), but the 
greatest proportional increases will occur where sensitization is uncommon (e.g., Germany, Poland, 
France). Higher pollen concentrations and a longer pollen season may also increase the severity of 
symptoms. Our model projections were driven predominantly by changes in climate (66%) but 
were also influenced by current trends in the spread of this invasive plant species. Assumptions 
about the rate at which ragweed spreads throughout Europe had a large influence upon the results.
conclusions: Our quantitative estimates indicate that ragweed pollen allergy will become a 
common health problem across Europe, expanding into areas where it is currently uncommon. 
Control of ragweed spread may be an important adaptation strategy in response to climate change.
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of the population is sensitized to ragweed 
(Arbes et al. 2005). This study focuses upon 
ragweed sensitization as a health consequence. 
Sensitization occurs when the human immune 
system has synthesized antibodies against the 
pollen and reacts when  reexposed, and it is 
a major risk factor for allergic diseases such 
as allergic rhinoconjunctivitis and asthma 
(Burbach et al. 2009).
Methods
This research is the culmination of a large 
multidisciplinary European Commission 
funded project (Atopica®; FP7 grant agree-
ment No. 282687). Specifically, for the 
present analysis, we integrated estimates of 
current and future ragweed pollen levels 
(previously developed within Atopica®) with 
published data on sensitization rates and 
population density. To estimate pollen levels, 
the Atopica® group first used a process-based 
model of weed growth, plant population 
dynamics, and competition to project the 
future expansion of ragweed’s range under 
different climate change scenarios (for details, 
see Storkey et al. 2014). These range results 
were then inputted into a system modeling 
plant invasion, pollen production, pollen 
release, and the atmospheric dispersion of 
pollen to simulate current (1986–2005) and 
future (2041–2060) ragweed pollen levels 
in Europe (for details, see Hamaoui-Laguel 
et al. 2015). To provide an estimate of 
uncertainty, these projections were produced 
for two different suites of regional climate/
pollen models (henceforth, CHIMERE and 
WRF/RegCM; Hamaoui-Laguel et al. 2015). 
These projections differ in their driving global 
climate models and in their representation of 
dynamical and physical atmospheric processes. 
Both model suites used CMIP5 data (Taylor 
et al. 2012) to account for changing land 
use patterns. In addition, pollen levels were 
simulated under two alternative greenhouse 
gas concentration scenarios [Representative 
Concentration Pathway (RCP) 8.5, which 
assumes high emissions, and RCP4.5, which 
assumes moderate emissions] and three 
different ragweed plant invasion scenarios 
(slow, rapid, and reference rates of spread) 
(Hamaoui-Laguel et al. 2015). The outputs 
from these models were daily ragweed pollen 
levels for 50 km × 50 km grid cells across 
Europe. Two estimates of current levels were 
produced (based on CHIMERE or WRF/
RegCM), as were 12 estimates of future levels 
(based on CHIMERE or WRF/RegCM, plus 
the 2 RCP and 3 plant invasion scenarios).
For the present analysis, these 14 estimates 
of current and future ragweed pollen were 
combined with health and population data 
to quantify their public health significance 
using ragweed sensitization rate (RSR) as a 
health consequence. Sensitization to ragweed 
is related to long-term pollen exposure; thus, 
these daily pollen outputs were aggregated to 
provide estimates, on a 50 km × 50 km grid, 
of average total season ragweed pollen.
To produce quantitative estimates of the 
potential impact of future ragweed pollen 
levels on RSRs, we first needed to generate a 
dose–response curve that would be representa-
tive of populations in locations with varying 
ragweed pollen levels in addition to charac-
teristics that might confound the association 
between pollen levels and RSRs. Although we 
considered using estimates from an existing 
multicenter study [e.g., from the Atopica® 
project (Atopica® 2014), the GA2LEN study 
(Heinzerling et al. 2009), or the European 
Community Respiratory Health Survey 
(ECRHS) (Bousquet et al. 2007)], none of 
these was considered suitable as they either 
did not sample across a wide range of ragweed 
pollen levels, focused upon a subset of the 
population, or were restricted to patients with 
existing allergic disease.
We instead performed a systematic review 
of Web of Science, Medline, BIOSIS, the 
Cochrane library, OpenGrey, and Google 
Scholar to generate a pooled estimate of the 
dose–response curve between ragweed and 
RSR based on all available studies that met 
a clearly established set of criteria. We used 
the following major search terms as Medical 
Subject Headings (MeSH) and all-field text 
words, as appropriate: immunology, pollen, 
aeroallergen, allergy, allergens, atopy, sensi-
tize (or sensitise), sensitized (or sensitised), 
sensitization (or sensitisation), hypersensi-
tivity, skin test, and Immunoglobulin E. The 
initial search identified 1,923 potentially 
relevant papers (see Figure S1). A first filter 
of the search results (see Table S1) retained 
50 papers that included estimates of RSRs 
for human populations within Europe (RSRs 
for 144 locations in total). Two authors 
(M.A. and I.L.) independently screened the 
remaining papers and extracted the following 
study information using standardized forms: 
location (country, place name), time period, 
sample characteristics (number, age, and 
population-based or allergy patients), the reac-
tivity marker used (e.g., skin prick test, specific 
ragweed Immunoglobulin E), and the RSR. 
We then further excluded 15 papers that did 
not clearly report the sensitivity to ragweed 
alone, that involved a highly restricted sample 
population (e.g., institutionalized elderly, 
weed-sensitive allergy patients, patients with 
symptoms restricted to the ragweed season), 
that were undertaken more than two decades 
ago (i.e., pre-1993), or that had a small sample 
size (< 50 individuals). Finally, for studies that 
reported multiple RSRs at a single location 
(such as a series of annual sensitization 
observations, observations over several time 
periods, or observations for more than one age 
cohort) we selected a single RSR value repre-
senting the baseline period and the general 
population. Ultimately, the review comprised 
66 location-specific RSRs from 35 studies and 
20 European countries (see Table S2).
Each location-specific RSR was matched 
(on geographic coordinates) to modeled 
average total season ragweed pollen levels for 
the baseline period (1986–2005) reported by 
Hamaoui-Laguel et al. (2015). We then used 
a generalized linear model to estimate the asso-
ciation between the natural  log– transformed 
mean pollen level (ln-mean pollen) at each 
location and the corresponding RSR for that 
location, adjusting for the study popula-
tion type (general population, i.e., a random 
sample of individuals, or atopic popula-
tion, e.g., allergy clinic patients). Although 
we considered adjusting for other factors 
known to affect RSR (e.g., skin prick test vs. 
allergen-specific IgE, atopic characteristics, 
and population characteristics such as age 
and sex), relevant data were often missing. 
The final model included 63 location-specific 
RSRs after excluding 3 locations with very low 
baseline pollen levels (< 10 grains/m3/year). 
Figure 1. The relationship between ragweed sensitization rate (percent) and mean pollen level (grains per 
cubic meter), adjusting for study population. The solid line represents the best fit relationship (natural log). 
a3 locations excluded owing to very low baseline pollen levels (< 10 grains/m3/year).
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The resulting model coefficient for ln-mean 
pollen was 5.85 [standard error (SE) 1.10, 
p-value < 0.001; 95% confidence interval 
(CI): 3.66, 8.04] with an adjusted R2 = 0.384. 
The coefficient for study type (atopic vs. 
general population) was 9.35 (SE 3.70, 
p-value 0.014; 95% CI: 1.94, 16.76). A plot 
of the association between mean pollen counts 
and RSR, adjusted for study  population type, 
is presented in Figure 1.
We then used the model coefficient 
and the estimated ln-mean pollen count in 
each 50 km × 50 km grid cell to estimate an 
RSR for each grid cell. This operation was 
performed on our 2 current and 12 future 
estimates of ragweed pollen across Europe. We 
combined the gridded RSR data with NUTS3 
boundaries (subdivisions of the 28 EU 
countries into regions of 150,000–800,000 
residents) and population data, to estimate 
the number of sensitized individuals at the 
NUTS3 level. These data were aggregated to 
the NUTS2 level (regions with 0.8–3 million 
residents) because many NUTS3 areas are 
smaller in size than the 50 km × 50 km grid 
cells. NUTS data were sourced from the 
Statistical Office of the European Union 
(Eurostat). For 12 non-EU European coun-
tries, we used boundaries and population data 
from the Global Administrative Areas database 
(DIVA-GIS 2015). Projections of population 
change were obtained from the World Bank 
databank (World Bank 2015) and applied 
equally to all NUTS2 areas within a country 
to estimate population counts for 2041–2060.
Burbach et al. (2009) indicated that 
only a proportion of patients sensitized to 
ragweed experience symptoms and presented 
estimates of clinically relevant sensitization 
rates for ragweed in different European coun-
tries. These estimates were obtained and were 
applied at the country level to the numbers of 
ragweed-sensitized individuals.
To estimate changes in the severity of 
ragweed allergy symptoms for sensitized indi-
viduals and the time period over which the 
symptoms are experienced, we also generated 
monthly maps of estimated ragweed pollen 
counts over the pollen season.
Results
The pollen RSR dose–response function 
was applied to the 14 ragweed pollen maps 
on a 50 km × 50 km grid, and the corre-
sponding population sensitized to ragweed 
at the NUTS2 level was mapped and 
tabulated at European and country levels. 
Initially focusing upon the reference plant 
invasion scenario, 6 RSR maps and country-
level data on the sensitized population were 
produced (2 current + 4 future). These 
differed according to the regional climate/
pollen model (CHIMERE or WRF/RegCM), 
time period (baseline or future), and RCP 
scenario used. These maps are presented in 
Figure S2 and Table S3. Estimates of the 
sensitized population based on airborne 
pollen levels generated using the WRF/
RegCM model suite were 27–39% higher 
than corresponding estimates based on the 
CHIMERE model suite for both the baseline 
period and the future period. A comparison 
of the spatial patterns of current and future 
sensitization indicated that these model diver-
gences were greatest in north and western 
Europe (Germany, Belgium, the Netherlands, 
and France), with models generated using 
the WRF/RegCM model suite indicating a 
greater sensitized population because of the 
higher levels of pollen in these locations. 
These results also indicated that the choice 
of RCP scenario makes little difference to the 
results by 2041–2060, irrespective of model 
suite; the sensitized populations differed 
by only ~5%. To provide an indication 
of the uncertainty, Table S3 also provides 
95% confidence intervals (CIs) based upon 
Figure 2. Percentage of population sensitized to ragweed pollen at baseline and in the far future; averaged results for WRF/RegCM and CHIMERE, RCP4.5, and 
reference invasion scenario. © EuroGeographics for the administrative boundaries. 
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the pollen RSR dose–response relationship. 
These indicate that there is relatively large 
uncertainty regarding the current and future 
sensitized population, a consequence of the 
divergent studies presented in Figure 1.
Here, the two model suites are consid-
ered to be equally plausible because they both 
show a similar performance in simulating 
pollen amounts compared with limited avail-
able observations (Hamaoui-Laguel et al. 
2015). Therefore, the estimated population 
affected was averaged across the two model 
suites for all further analysis. However, in the 
numerical results, the data for both model 
suites are additionally reported in square 
brackets as an indicator of uncertainty; the 
following format is used: [CHIMERE, WRF/
RegCM]. All subsequent results are presented 
for RCP4.5 (i.e., a moderate degree of climate 
change) for the sake of simplicity, bearing 
in mind that the numbers of sensitized indi-
viduals in the future are very similar between 
RCP4.5 and RCP8.5.
Our best estimates of the current and 
future population sensitized to ragweed 
from the pollen RSR dose–response rela-
tionship shown in Figure 1 are presented in 
Figure 2. The sensitized population numbers 
are presented in Table 1 at the country level 
and are summed for EU28 and non-EU28 
countries and for Europe as a whole. Overall, 
our estimates indicate that under the RCP4.5 
emissions scenario and the reference ragweed 
invasion scenario, the number of people sensi-
tized to ragweed in Europe would increase 
from approximately 33 million (27 million 
and 38 million based on CHIMERE and 
WRF/RegCM, respectively) at baseline to 
77 million (68 million and 86 million 
based on CHIMERE and WRF/RegCM, 
respectively) in 2041–2060 owing to higher 
pollen counts affecting a larger spatial area. 
Sensitization is projected to increase in coun-
tries with an existing ragweed problem, such 
as Romania and Italy, partly as a result of 
increased pollen production by established 
plant populations; however, the greatest 
proportional increases are likely to be in areas 
where ragweed sensitization is currently rela-
tively uncommon, such as Germany, France, 
and Poland. By 2041–2060, sensitization to 
ragweed will be widespread across the whole 
of Europe except for Scandinavia, the Baltic 
States, most of Spain, Portugal, and Ireland.
Table 1. Current and future populations sensitized to ragweed pollen for three different plant invasion scenarios. Data are average of the CHIMERE and 
WRF/RegCM model suites for Representative Concentration Pathway (RCP) 4.5 [CHIMERE and WRF/RegCM values given in brackets].
Country
Population sensitized in thousands [CHIMERE, WRF/RegCM values]
Baseline
2041–2060
Reference  
ragweed invasion scenario
Slow  
ragweed invasion scenario
Rapid  
ragweed invasion scenario
Austria 890 [868, 912] 1,749 [1,636, 1,863] 1,354 [1,282, 1,427] 2,061 [1,954, 2,169]
Belgium 923 [732, 1,115] 2,364 [2,143, 2,585] 1,616 [1,452, 1,780] 2,767 [2,519, 3,015]
Bulgaria 1,150 [1,135, 1,165] 1,763 [1,614, 1,912] 1,442 [1,350, 1,535] 2,066 [1,889, 2,243]
Croatia 873 [804, 943] 1,098 [1,041, 1,156] 1,037 [973, 1,102] 1,169 [1,124, 1,214]
Cyprus 7 [0, 15] 36 [1, 71] 15 [0, 31] 77 [33, 120]
Czech Republic 487 [409, 565] 1,943 [1,756, 2,130] 1,150 [1,054, 1,246] 2,844 [2,737, 2,950]
Denmark 0 [0, 0] 96 [29, 163] 3 [0, 7] 533 [426, 640]
Estonia 0 [0, 0] 0 [0, 0] 0 [0, 0] 5 [3, 7]
Finland 0 [0, 0] 0 [0, 0] 0 [0, 0] 0 [0, 0]
France 3,233 [2,256, 4,210] 10,716 [8,849, 12,582] 5,989 [4,480, 7,498] 15,646 [14,066, 17,225]
Germany 4,688 [2,282, 7,095] 15,689 [13,337, 18,041] 9,321 [6,882, 11,759] 20,928 [19,129, 22,727]
Greece 831 [487, 1,176] 1,764 [1,341, 2,188] 1,284 [911, 1,658] 2,320 [1,908, 2,732]
Hungary 2,289 [2,668, 1,910] 2,899 [3,069, 2,729] 2,721 [2,979, 2,464] 3,006 [3,098, 2,914]
Ireland 0 [0, 0] 4 [0, 8] 0 [0, 0] 82 [0, 164]
Italy 4,786 [4,097, 5,474] 10,110 [9,563, 10,656] 7,480 [6,846, 8,115] 13,450 [13,079, 13,821]
Latvia 0 [0, 0] 0 [0, 0] 0 [0, 0] 77 [78, 75]
Lithuania 0 [0, 0] 6 [11, 2] 0 [0, 0] 224 [245, 204]
Luxembourg 15 [0, 31] 78 [57, 98] 33 [8, 58] 124 [106, 141]
Malta 0 [0, 0] 28 [18, 38] 12 [5, 19] 49 [38, 60]
Netherlands 2,224 [1,300, 3,148] 3,489 [2,863, 4,115] 2,894 [2,135, 3,654] 3,862 [3,374, 4,350]
Poland 1,123 [1,251, 994] 4,397 [4,175, 4,619] 2,437 [2,467, 2,408] 8,733 [8,382, 9,084]
Portugal 0 [0, 0] 0 [0, 0] 0 [0, 0] 356 [0, 712]
Romania 3,097 [3,045, 3,148] 4,772 [4,473, 5,072] 4,016 [3,796, 4,237] 5,500 [5,062, 5,938]
Slovakia 626 [790, 462] 1,160 [1,221, 1,100] 895 [1,004, 786] 1,438 [1,419, 1,457]
Slovenia 304 [281, 327] 424 [397, 451] 385 [364, 406] 470 [442, 497]
Spain 21 [0, 42] 447 [35, 858] 137 [1, 272] 2,670 [939, 4,401]
Sweden 0 [0, 0] 13 [1, 25] 0 [0, 0] 153 [114, 192]
United Kingdom 1,196 [1,008, 1,384] 6,173 [5,113, 7,232] 2,631 [1,988, 3,273] 10,023 [9,270, 10,776]
Sum EU28 28,764 [23,413, 34,116] 71,218 [62,743, 79,693] 46,855 [39,975, 53,736] 100,631 [91,434, 109,828]
Albania 394 [400, 388] 626 [580, 673] 513 [496, 529] 784 [727, 840]
Andorra 0 [0, 0] 2 [0, 5] 0 [0, 1] 9 [7, 11]
Bosnia and Herzegovina 703 [682, 724] 914 [869, 958] 855 [819, 890] 980 [937, 1,023]
Iceland 0 [0, 0] 0 [0, 0] 0 [0, 0] 0 [0, 0]
Kosovo 259 [196, 323] 429 [391, 468] 347 [287, 407] 498 [492, 504]
Liechtenstein 1 [0, 1] 3 [1, 4] 1 [0, 3] 4 [3, 6]
FYR Macedonia 300 [291, 308] 486 [449, 524] 395 [369, 420] 584 [562, 605]
Montenegro 78 [56, 101] 124 [101, 146] 105 [81, 129] 148 [131, 164]
Norway 0 [0, 0] 0 [0, 0] 0 [0, 0] 4 [0, 7]
San Marino 2 [2, 2] 5 [5, 4] 4 [4, 4] 6 [6, 6]
Serbia 1,708 [1,731, 1,685] 2,073 [2,042, 2,105] 1,964 [1,928, 1,999] 2,140 [2,129, 2,151]
Switzerland 376 [135, 618] 954 [650, 1,257] 650 [346, 954] 1,498 [1,222, 1,774]
Sum non-EU28 3,822 [3,493, 4,151] 5,615 [5,087, 6,144] 4,833 [4,331, 5,335] 6,654 [6,216, 7,091]
Sum Europe 32,586 [26,905, 38,266] 76,833 [67,829, 85,837] 51,688 [44,305, 59,071] 107,285 [97,650, 116,919]
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Table 1 also examines the impact of 
ragweed invasion scenario upon sensitiza-
tion rates. Under the reference plant invasion 
scenario, the population sensitized to ragweed 
at the European level is estimated to increase 
from 33 million (range: 27 million–38 million) 
to 77 million (range: 68 million–86 million) 
by 2041–2060. In comparison, a slow plant 
invasion scenario reduces the projected future 
value to approximately 52 million (range: 
44 million–59 million), whereas a rapid plant 
invasion scenario increases the projected 
value to approximately 107 million (range: 
98 million–117 million).
The sensitization rates presented in 
Table 1 were converted into estimates of 
clinically relevant sensitization rates using 
data from Burbach et al. (2009). These results 
are presented in Table S4, indicating that 
compared with the population sensitized to 
ragweed, the population clinically sensitized 
to ragweed in Europe is approximately 25% 
lower for both the baseline and 2041–2060. 
Table S4 also shows that future changes in 
the European population base do not greatly 
affect our projections, but they suggest smaller 
impacts in countries with decreasing popula-
tions such as Germany, Poland, and Romania, 
and accentuated impacts in countries with 
increasing populations (e.g., France, the 
United Kingdom).
To estimate the potential impacts of future 
climate-related changes on allergy symptoms 
for individuals sensitized to ragweed, maps 
of average total season pollen (mid-July–
mid-October) subdivided into monthly periods 
were produced and are displayed in Figure 3. 
These estimates indicate that particularly across 
France and northwest Italy, airborne pollen is 
likely to be present much earlier in the season 
(mid-July–mid-August) because of accelerated 
plant development. In the peak pollen months 
(mid-August–mid-September), more ragweed 
pollen is likely to be present across Europe, 
with the greatest increases occurring away 
from current pollen hotspots. Our projections 
suggest that pollen will persist in the air across 
most of Europe in the mid-September to mid-
October period, likely as a result of delayed 
frosts (Storkey et al. 2014).
Discussion
It has been argued that climate change is likely 
to affect pollen-related allergy (Bielory et al. 
2012). To our knowledge, this is the first 
study to fully model the potential impacts of 
climate change on ragweed plant distribution, 
plant productivity, and pollen production and 
dispersal, as well as the resulting impacts on 
pollen concentrations and allergic sensitization.
We estimate that across Europe, sensitiza-
tion to ragweed is likely to more than double 
by 2041–2060 and that populations across 
most of Europe are likely to be affected. 
Our projections indicate that sensitization 
will continue to increase in countries with an 
existing ragweed problem, but the greatest 
proportional increases will be in areas where 
ragweed sensitization is currently relatively 
uncommon. Much of the projected change 
is due to the expected northward expan-
sion of ragweed, consistent with the expan-
sion already observed in the United States 
(Ziska et al. 2011). Our estimates indicate 
that ragweed-sensitized individuals may 
experience more severe symptoms because of 
increased ragweed pollen concentrations and 
a longer pollen season lasting into September 
and October across much of Europe. These 
projected changes are predominantly related 
to climate and associated land-use change 
(66%; Hamaoui-Laguel et al. 2015) but 
Figure 3. Monthly current (baseline) and future (2041–2060) ragweed pollen counts (grains per cubic 
meter) across Europe. Data are the average of the CHIMERE and WRF/RegCM model suites for RCP4.5 and 
a reference plant invasion scenario. © EuroGeographics for the administrative boundaries.
Lake et al.
390 volume 125 | number 3 | March 2017 • Environmental Health Perspectives
also include the dispersal of this alien plant 
through Europe even without climate change.
One striking feature of the results is the 
large influence of the plant invasion scenario. 
The reference plant invasion scenario uses the 
common assumption that the flux of seeds 
is inversely proportional to the square of the 
distance (Hamaoui-Laguel et al. 2015). The 
slow and rapid plant invasion scenarios were 
generated by altering the proportionality 
coefficient based upon the ranges reported in 
previous research (Richter et al. 2013). The 
slow plant invasion scenario assumes a limited 
expansion in the range of ragweed, and this 
scenario more than halves the overall estimated 
increase in sensitization to ragweed projected 
by 2041–2060 under RCP4.5. Thus, it 
strongly suggests that control of ragweed is 
important for public health and as an adapta-
tion strategy against the impacts of climate 
change. However, control of existing plants is 
difficult owing to ragweed’s long-lived seeds, 
to its ability to evolve herbicide resistance, and 
to its capacity to resprout following cutting 
(Brewer and Oliver 2009). Ragweed thrives 
on regular land disturbance; hence, manage-
ment of land is key to its control (Storkey et al. 
2014). Controlling long-distance seed dispersal 
is also important for preventing plant spread, 
which is predominantly associated with human 
activity. Therefore, controls over contaminated 
seed and monitoring areas prone to ragweed 
invasion are key elements to limiting spread 
(Bullock 2010).
We also examined the impact of different 
Representative Concentration Pathways 
(RCP 4.5 and 8.5) and highlighted that these 
pathways make little difference to the numbers 
of individuals sensitized to ragweed. This 
outcome is likely to be a result of saturation of 
the CO2 fertilization effect at higher concen-
trations; it may also result from the relatively 
similar climate between the two RCPs within 
the relatively short future time frame of our 
analysis. Projected changes to the population 
numbers and distribution across Europe had a 
relatively minor influence on our results.
This study emphasizes the multiple steps 
required to model the impact of climate 
change on pollen allergy. There are assump-
tions and uncertainties associated with each 
step of the process, and as far as possible, 
we have been transparent about them and 
about their impacts upon the results. We 
compared two regional climate model suites 
(WRF/RegCM, CHIMERE) that differ in 
atmospheric processing, in pollen modeling, 
and in the driving global climate model, 
and we found responses in the same direc-
tion, although with substantial differences in 
magnitude. This finding highlights the need 
for multimodel approaches to the problem of 
future pollen simulation. Our research was 
highly sensitive to the assumptions concerning 
the plant invasion scenarios, which emphasizes 
the importance of dispersal control [e.g., the 
measures highlighted by Bullock (2010)] as an 
effective tool to minimize ragweed allergy in 
the future.
A notable element of uncertainty is the 
pollen/RSR dose–response relationship 
(adjusted R2 = 38.4%). This low value is 
a function of the limited number of studies 
reporting sensitization to ragweed and the lack 
of standardization across studies. We have also 
assumed that the dose–response relationship 
between pollen and allergy is identical across 
Europe, whereas differences in factors such as 
genetic predisposition may lead to a differential 
impact across the continent.
In addition to climate change, plant 
invasion and population change, other factors 
may affect ragweed allergy moving into the 
future. By 2041–2060, levels of ozone air 
pollution across Europe are likely to decrease 
(Colette et al. 2012), potentially suppressing 
the allergenicity of ragweed pollen (Pasqualini 
et al. 2011). Conversely, ragweed pollen 
allergenicity may be elevated through higher 
atmospheric CO2 levels and increasing 
drought (El Kelish et al. 2014; Singer et al. 
2005). Inclusion of changing allergenicity is 
a priority for future research. By 2041–2060, 
the median age of the European population 
is projected to increase from 38 to 52 years 
(World Bank 2015), and ragweed allergy is 
more difficult to treat in aged populations 
owing to greater difficulty in diagnosis and 
limited treatment options because of comor-
bidities and ongoing medication use (Cardona 
et al. 2011). Appropriate management and use 
of medication can significantly improve allergy 
symptoms (Pawankar 2014). Such manage-
ment can be economically beneficial, and 
appropriate therapy for allergic diseases can be 
5% of the cost of untreated disease (Zuberbier 
et al. 2014). Therefore, the overall impact of 
increasing ragweed allergy will be influenced 
by the adaptation capacities of individuals and 
by those of healthcare systems across Europe. 
Ebi (2014) argued that the capacity of health-
care systems to adapt to climate change will 
depend upon the development pathways taken 
by individual countries. Pathways leading to 
increased inequalities and fragmentation in 
society present most of the challenges to adap-
tation (Ebi 2014) and hence to the potential 
problem of increasing ragweed allergy.
Conclusions
Our projections indicate that ragweed pollen 
allergy will become a common health problem 
across much of Europe and that sensitization 
to ragweed will more than double, increasing 
from the current total of 33 million to 
77 million people by 2041–2060. According 
to our projections, sensitization will increase 
in countries with an existing ragweed problem 
(e.g., Hungary, the Balkans) but the greatest 
proportional increases are projected for coun-
tries where sensitization is now relatively 
uncommon (e.g., Germany, Poland, France). 
Our estimates also indicate that sensitized 
individuals may experience more severe 
symptoms as a consequence of higher ragweed 
pollen levels and an extended pollen season 
that will last into September and October 
across much of Europe. Our projections are 
primarily driven by assumptions regarding 
climate change (66%) but also reflect current 
trends in the spread of this invasive plant 
species across Europe. The projected health 
consequences are highly dependent upon 
the rate at which ragweed spreads, which is 
strongly related to control measures against 
the spread of this plant species (Bullock 2010). 
This relationship emphasizes that control of 
ragweed spread is essential for public health 
and as an adaptation strategy in response to 
climate change.
To our knowledge, this is the first study 
to model the future impacts of climate change 
on plant distribution, plant life cycles, and 
pollen production and dispersal, as well as 
their subsequent impacts on pollen concen-
trations and allergy. Climate change conse-
quences will not be restricted to ragweed, 
and a recent review has highlighted a range 
of other pollen-producing species that may be 
affected (Beggs 2015). Our methods provide 
a framework for other studies investigating 
the impacts of climate change on pollen 
allergy for these other species.
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